The balloon catheter is a flexible, tubular device with a balloon at its tip that is used to create, enlarge or remove blockage of a passageway within the body, by passing it through body channels. The balloon tip can be expanded by water or air to remove the blockage or to expand partly closed passageway during surgical procedure. The balloon catheter is used to treat heart related disease such as coronary heart disease, which are caused due to diabetes, high blood pressure, and high cholesterol level in blood. During the treatment of coronary heart disease, the balloon catheter helps to allow the blood flow from arteries by making a passageway, blocked due to excess cholesterol, avoiding open heart surgery.

Moreover, the balloon catheter plays a major role in angioplasty to treat atherosclerosis by widening the narrowed or obstructed arteries or veins. As, the procedure is minimally invasive, it is economically beneficial to the patient and helps patient to get cure rapidly as compared to open surgical procedure.

Market Dynamics

Rising incidence of coronary heart disease cases due to increasing prevalence of diabetes, high blood pressure cases, and increasing number of smokers across the globe is expected to drive demand for balloon catheters over the forecast period. For instance, according to the World Health Organization (WHO), in 2017 around 17.9 million death cases were reported globally due to cardiovascular disease.

Moreover, product launches by key players is expected to drive the balloon catheters market growth over the forecast period. For instance, in September 2018, SIS Medical, a Switzerland-based manufacturer of innovative cardiology products launched three models of its balloon catheters, EasyT, NIC 1.1 hydro, and NIC Nano hydro. The novel balloon catheters are used in interventional cardiology to dilate narrowed and closed heart vessels. Furthermore, in 2019, the company received CE marking for these products to be marketed in Europe. The company is also planning to facilitate the registration of these products in Asia Pacific, Latin America, and few Middle East countries.

Thus, rising prevalence of coronary heart disease is expected to provide a favorable opportunity for key players to develop and launch innovative balloon catheters to use during interventional cardiology services, which is expected to drive the global balloon catheters market growth over the forecast period.

Key features of the study

• This report provides in-depth analysis of the balloon catheters market and provides market size (USD Mn) and cumulative annual growth rate (CAGR) (%) for the forecast period (2026–2033)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global balloon catheters market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Key players covered as a part of this study include Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B. Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc. Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launches, market expansion, and marketing tactics
• The global balloon catheters market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical device companies, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the balloon catheters market

Market Segmentation

• By Product Type
  • Over-the-wire (OTW) Balloon Catheters
  • Rapid Exchange (RX) Balloon Catheters
  • Fixed-wire (FW) Balloon Catheters
• By Balloon Type
  • Noncompliant (High-pressure) Balloons
  • Semi-compliant (Midpressure) Balloons
  • Compliant (Elastomeric) Balloons
• By Material
  • Polyurethane
  • Nylon
  • Others
• By Regional Insights
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Bard Medical Division
  • Braun Melsungen AG
  • Johnson & Johnson
  • Teleflex Incorporated
  • Medtronic, Plc
  • Edwards Lifesciences Corporation
  • Vascular Solutions, Inc.